ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - fluticasone propionate - תרחיף - fluticasone propionate 400 mcg/actuation - fluticasone - fluticasone - flixonase nasule drops are indicated for the regular treatment of nasal polyps and associated symptoms of nasal obstruction.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - fluticasone furoate - ספריי - fluticasone furoate 27.5 mcg/dose - fluticasone furoate - fluticasone - avamys (fluticasone furoate) nasal spray is indicated for the treatment of the symptoms of seasonal and perennial allergic rhinitis in patients aged 2 years and older.

ישראל - עברית - Ministry of Health

teva israel ltd - rasagiline as mesylate - טבליה - rasagiline as mesylate 1 mg - rasagiline - rasagiline - azilect is indicated for the treatment of idiopathic parkinson's disease (pd) as monotherapy (without levodopa)or as adjunct therapy (with levodopa) in patients with end of dose fluctuations.

ישראל - עברית - Ministry of Health

teva pharmaceutical industries ltd, israel - rasagiline as mesylate - טבליה - rasagiline as mesylate 1 mg - rasagiline - rasagiline - azilect is indicated for the treatment of idiopathic parkinson's disease (pd) as monotherapy (without levodopa)or as adjunct therapy (with levodopa) in patients with end of dose fluctuations.

ישראל - עברית - Ministry of Health

teva pharmaceutical industries ltd, israel - rasagiline as mesylate - טבליה - rasagiline as mesylate 1 mg - rasagiline - rasagiline - azilect is indicated for the treatment of idiopathic parkinson's disease (pd) as monotherapy (without levodopa)or as adjunct therapy (with levodopa) in patients with end of dose fluctuations.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - fluticasone propionate - תרחיף - fluticasone propionate 0.05 g / 100 g - fluticasone - fluticasone - prophylaxis and treatment of seasonal allergic rhinitis including hayfever, and perennial rhinitis. perenial rhinitis in children of the age of 4 years.

ישראל - עברית - Ministry of Health

trima israel pharmaceutical products maabarot ltd - fluticasone propionate - תרחיף - fluticasone propionate 0.05 %w/w - fluticasone - fluticasone - prophylaxis and treatment of seasonal allergic rhinitis including hay fever and perenial rhinitis.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - fluticasone propionate; formoterol fumarate dihydrate - תרחיף בלחץ לשאיפה - fluticasone propionate 0.05 mg/dose; formoterol fumarate dihydrate 0.005 mg/dose - fluticasone - fluticasone - the regular treatment of asthma where use of a combination product (an inhaled corticosteroid and a long -acting ?2 agonist) is appropriate:• for patients not adequately controlled with inhaled corticosteroids and ‘as required’ inhaled short -acting ?2 agonist.• for patients already adequately controlled on both an inhaled corticosteroid and a long-acting ?2 agonist.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - fluticasone propionate; formoterol fumarate dihydrate - תרחיף בלחץ לשאיפה - fluticasone propionate 0.125 mg/dose; formoterol fumarate dihydrate 0.005 mg/dose - fluticasone - fluticasone - the regular treatment of asthma where use of a combination product (an inhaled corticosteroid and a long -acting ?2 agonist) is appropriate:• for patients not adequately controlled with inhaled corticosteroids and ‘as required’ inhaled short -acting ?2 agonist.• for patients already adequately controlled on both an inhaled corticosteroid and a long-acting ?2 agonist.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - fluticasone propionate; formoterol fumarate dihydrate - תרחיף בלחץ לשאיפה - fluticasone propionate 0.25 mg/dose; formoterol fumarate dihydrate 0.01 mg/dose - fluticasone - fluticasone - the regular treatment of asthma where use of a combination product (an inhaled corticosteroid and a long -acting ?2 agonist) is appropriate:• for patients not adequately controlled with inhaled corticosteroids and ‘as required’ inhaled short -acting ?2 agonist.• for patients already adequately controlled on both an inhaled corticosteroid and a long-acting ?2 agonist.